Replies to post #231972 on Amarin Corp Plc (AMRN)

[jfmcrr]

1) 5-10 P/S; faster growth is worth more, VRTX is 14. 20 is quite rich. It may stay at 20 +/- for some time, but not forever; as it gets some stability, it likely will moderate.

2) bcs I think with the rev growth the downside is limited. However, I'd believe the SP will grow, just not to the moon and just not as fast as many here say.


I share a similar sentiment. I don't think we will breach $30 without a buyout. My strategy will be to sell the news when the label is approved and buy back in after the correction.

Trading account, yes.

IRA's, diversify some into names just getting started. I dumped almost all of my names back in 9/17. I kinda regret chasing GBT and AUPH now because I didn't sell some AMRN at/by ADA.

[BostonTrader]

Doesn’t it matter which label is actually approved? If primary isn’t worth $30, something is terribly wrong.

[rafunrafun]

A -

I share a similar sentiment. I don't think we will breach $30 without a buyout. My strategy will be to sell the news when the label is approved and buy back in after the correction.

Confused, please help.

You don't think that ARMN will reach $30, but you think there will a correction? How could there be a correction if this will not reach $30? Are you saying that it will "jump" to a whopping $25'ish after FDA & generic settlement/win and because that $25'ish PPS would be so high, a correction would follow?

In other words, a correction from what?

[Biobillionair]

MRC is going long?! BB

[tmac20]

Atom - The only problem with selling the news on this one is that a buyout could literally happen within hours of the label. I'll bet there are documents just sitting there waiting to be autographed. Up until this point, that strategy(sell the news) would have paid off nicely but you can only go to the well so many times and then you fall in. I think the only "correction" we might see is if the label is not as broad as Amarin would like but I don't think that will keep the stock down for long. Amarin still has a blockbuster with a 16-0 AdCom to back it up. I guess everyone's situation is different and there is a lot of ways to make money on this stock.

[IgnoranceIsBliss]

I don't think we will breach $30 without a buyout.

This could well be true if the lens is a short-term one.

$30 is $12bn market cap. Which is more or less consistent with conservative peak sales of like $3 to 3.5bn. It is possible the stink-ass Wall Street consensus could be in that range, given how stupid they are.

And if Thero does his radio silent thing, which would not be shocking over the holidays into JPM, then you could well be right Atom. We could streak to the high 20's, and then see profit taking back to the 25ish range pre-JPM.

And that would be a buying opportunity. And you're saying you'd hit that.

I'm not sure this is right of course, but there is nothing irrational about it.

[pax33]

Okay everyone. We need to sell so Steven can cover on Monday.

[amarinbullfromchicago]

Wait 40% of your aum is short amarin and long puts right? How can you buy back something you’re short?